Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)Brigette Ma, Anthony T.�C. Chan, Kwok Wai Lo et al.|Journal of Clinical Oncology|2018Cited by 473
Abstract CT076: Multicenter phase II study of nivolumab in previously treated patients with recurrent and metastatic non-keratinizing nasopharyngeal carcinoma - Mayo clinic Phase 2 Consortium P2C-MN026, NCI9742, NCT02339558Brigette Ma, Anthony T.�C. Chan, Boon Cher Goh et al.|Cancer Research|2017Cited by 2